Audiology findings in patients with teprotumumab associated otologic symptoms
Purpose: To report a case series of subjective and objective hearing function changes associated with teprotumumab treatment for thyroid eye disease. Observations: A 74-year-old female with a history of Graves' disease with thyroid eye disease was treated with teprotumumab. She had a history of...
Main Authors: | Caroline Y. Yu, Tatiana Correa, Brittany A. Simmons, Marlan R. Hansen, Erin M. Shriver |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993621002115 |
Similar Items
-
Audiologic Demonstration of Ototoxicity From Teprotumumab Treatment in a Patient With Thyroid Eye Disease
by: Najjar, W., et al.
Published: (2022) -
A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
by: Myra B. Safo, et al.
Published: (2021-06-01) -
Teprotumumab: a disease modifying treatment for graves’ orbitopathy
by: Michelle Ting, et al.
Published: (2020-07-01) -
Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
by: Nickisa M. Hodgson, et al.
Published: (2019-12-01) -
Early experience with teprotumumab for chronic thyroid eye disease
by: Daniel J. Ozzello, et al.
Published: (2020-09-01)